Revolving Leadership Door At California Biotech Startups
Martin Shrkreli's old job as CEO at KaloBios Pharmaceuticals has been filled. And the head of the University of California's biotech incubator is leaving the school system for a private-public initiative.
The San Francisco Business Journal:
New Space, CEO for Onetime Martin Shkreli Biotech Fixer-Upper
KaloBios Pharmaceuticals has a new CEO and is on its way to smaller, cheaper space in Brisbane. (Leuty, 3/5)
The San Francisco Business Journal:
UC Loses Startup Visionary To Biotech Incubator, Venture Fund He Helped Create
Douglas Crawford, an architect of the University of California's effort to swing biotechnology from academic lab benches to commercial partners and spinouts, has left UC to work full time at a public-private incubator and early-stage venture fund firm he was instrumental in creating. As associate director of QB3 — or the California Institute for Quantitative Biosciences — Crawford's fingerprints are on scores of life sciences companies that have set up shop or spun out of the institute's four Bay Area incubators and handful of related programs over the past 12 years. He also was instrumental in forging a network of startup spaces, from the East Bay to near Stanford University, to help dozens more young biotech companies move from bench to bedside. (Leuty, 3/6)